Showing results (831-840 of 907) with videos related to

Sort By:
Pageof 91
Journal of Cancer Research and Clinical Oncology|July 17, 2020
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12Ji Hyun Park, Sang Hoon Chun, Yun-Gyoo Lee, et al.
Scientific Reports|March 24, 2021
Low-dose aspirin was associated with an increased risk of cardiovascular events in patients with chronic kidney disease patients and low bodyweight: results from KNOW-CKD studyYun Jung Oh, Ae Jin Kim, Han Ro, et al.
ACS Nano|September 17, 2020
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid TumorsKuo-Ching Mei, Yu-Pei Liao, Jinhong Jiang, et al.
Endocrine Journal|July 28, 2015
Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditisJin Wook Yi, Ji Yeon Park, Ji-Youn Sung, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 15, 2014
Fat deposition in the tunica muscularis and decrease of interstitial cells of Cajal and nNOS-positive neuronal cells in the aged rat colonHyun Jin Jo, Nayoung Kim, Ryoung Hee Nam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Whole-Genome Sequencing Reveals Mutational Signatures Related to Radiation-Induced Sarcomas and DNA-Damage-Repair PathwaysEunji Kim, Dong-Jin Han, Byoung Hyuck Kim, et al.
Tumori|October 10, 2014
Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinomaJae Joon Han, Yu Jung Kim, Jin Won Kim, et al.
ACS Nano|December 12, 2018
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon CancerXiangsheng Liu, Jinhong Jiang, Ryan Chan, et al.
Kidney Research and Clinical Practice|April 11, 2017
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in KoreaRan-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice|April 10, 2018
Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78]Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Pageof 91